文献速递心力衰竭与心肌病冠心病

心源性休克诊断后72小时内休克严重程度的连续评估:CSWG报告

Serial Shock Severity Assessment Within 72 Hours After Diagnosis: A Cardiogenic Shock Working Group Report.
PubMed 文献 · J Am Coll Cardiol · 2024-08-01

本研究基于多中心CSWG注册登记,对3268例心源性休克患者(57%为心衰相关,27%为心梗相关)在诊断时及24、48、72小时进行CSWG-SCAI分期评估。多数患者在诊断后24小时内SCAI分期发生变化,B期患者24小时内恶化风险高且伴随死亡率增加,24小时后分期变化较小。

要点

  • 多数心源性休克患者诊断后24小时内SCAI分期改变。
  • B期患者24小时内恶化风险高,与死亡率增加相关。
  • 24小时内进展至E期或持续E期者预后最差。

核心结论

  • 多数心源性休克患者在诊断后24小时内SCAI分期发生变化,B期患者恶化风险高且死亡率增加,早期识别和连续评估可改善风险分层。

研究设计与样本

  • 多中心CSWG注册登记研究,共纳入3268例心源性休克患者,其中57%为心衰相关,27%为心梗相关。
  • 在诊断时及24、48、72小时计算CSWG-SCAI分期。

主要发现

  • 诊断时分期:B期593例(18.1%),C期528例(16.2%),D期1659例(50.8%),非心脏骤停E期488例(14.9%)。
  • 24小时时,超过50%的B期和C期患者恶化,但86%的D期患者仍为D期;E期患者中54%改善至D期,36%仍为E期。
  • 24小时后SCAI分期变化极小;MI-CS与HF-CS组的SCAI分期轨迹相似。
  • 24小时内,SCAI分期恶化或改善的患者未调整死亡率分别为44.6%和34.2%。
  • 24小时内出现或进展至E期的患者预后最差;存活者乳酸低于非存活者。

临床怎么用

  • 对心源性休克患者应在诊断后24小时内进行连续SCAI分期评估,尤其关注B期患者的恶化风险。
  • 早期识别和连续评估有助于改善风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Cardiogenic Shock Working Group-modified Society for Cardiovascular Angiography and Interventions (CSWG-SCAI) staging was developed to risk stratify cardiogenic shock (CS) severity. Data showing progressive changes in SCAI stages and outcomes are limited. OBJECTIVES: We investigated serial changes in CSWG-SCAI stages and outcomes of patients presenting with cardiogenic shock complicating acute myocardial infarction (MI-CS) and heart failure-related CS (HF-CS). METHODS: The multicenter CSWG registry was queried. CSWG-SCAI stages were computed at CS diagnosis and 24, 48, and 72 hours. RESULTS: A total of 3,268 patients (57% HF-CS; 27% MI-CS) were included. At CS diagnosis, CSWG-SCAI stage breakdown was 593 (18.1%) stage B, 528 (16.2%) stage C, 1,659 (50.8%) stage D, and 488 (14.9%) noncardiac arrest stage E. At 24 hours, >50% of stages B and C patients worsened, but 86% of stage D patients stayed at stage D. Among stage E patients, 54% improved to stage D and 36% stayed at stage E by 24 hours. Minimal SCAI stage changes occurred beyond 24 hours. SCAI stage trajectories were similar between MI-CS and HF-CS groups. Within 24 hours, unadjusted mortality rates of patients with any SCAI stage worsening or improving were 44.6% and 34.2%, respectively. Patients who presented in or progressed to stage E by 24 hours had the worst prognosis. Survivors had lower lactate than nonsurvivors. CONCLUSIONS: Most patients with CS changed SCAI stages within 24 hours from CS diagnosis. Stage B patients were at high risk of worsening shock severity by 24 hours, associated with excess mortality. Early CS recognition and serial assessment may improve risk stratification.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Ton VK, Li S, John K, et al. Serial Shock Severity Assessment Within 72 Hours After Diagnosis: A Cardiogenic Shock Working Group Report. J Am Coll Cardiol. 2024. PMID: 39217545. doi:10.1016/j.jacc.2024.04.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。